Stay updated on JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial
Sign up to get notified when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.

Latest updates to the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added, and the previous lapse-in-government-funding notice and Revision: v3.4.1 were removed. These are administrative updates to the site. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedUpdated page with a government funding notice banner and a software revision tag (v3.4.1) while removing the previous revision tag (v3.4.0); no study data or core content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display toggle and updated footer wording to reflect QC criteria and FEAR Act information, including Revision: v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this appears to be a minor maintenance update. No substantive study content or fields appear to be altered.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now includes a dedicated Locations section with sites in Alabama, Arizona, California, New York, Ohio, Oklahoma, Texas, and Washington, plus an updated revision tag (v3.3.3). The HHS Vulnerability Disclosure link was removed.SummaryDifference0.9%

- Check92 days agoChange DetectedThe revision label in the page footer updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.